Use access key #2 to skip to page content.
$5.64 -0.07 (-1.23%)
9/5/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

2

Avatar TDJ1 (< 20) Submitted: 8/23/06 9:10 PM : Outperform Start Price: $8.28 EXEL Score: -27.44

This one might take a couple years to show fruit. But, when EXEL begins to excel, it will produce more than enough fruit to make up for the lean years. Get in now and wait for the 20-bagger.

Report this Post Replies: 1 | Reply

Avatar biotiempo (< 20) Submitted: 4/06/07 9:35 PM

Recs: 0 | Rec This

Could be right on. Small cap biotechs are my main interest and this one is on my top 10 list. Hope we are right.

Report this Post Reply

Featured Broker Partners